Apex Biotechnology Corp. Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2024: USD 7.04 M

Apex Biotechnology Corp. Selling, General, and Administrative Expenses (SG&A) is USD 7.04 M for the year ending December 31, 2024, a -3.57% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.
  • Apex Biotechnology Corp. Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2023 was USD 7.30 M, a -4.64% change year over year.
  • Apex Biotechnology Corp. Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2022 was USD 7.66 M, a -2.04% change year over year.
  • Apex Biotechnology Corp. Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2021 was USD 7.82 M, a 10.81% change year over year.
  • Apex Biotechnology Corp. Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2020 was USD 7.06 M, a -8.95% change year over year.
Key Data
Date Selling, General, and Administrative Expenses (SG&A) Research and Development (R&D) Expenses Revenue Revenue